Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 17;32(8):709-719.
doi: 10.1093/ajh/hpz052.

Novel Contributors and Mechanisms of Cellular Senescence in Hypertension-Associated Premature Vascular Aging

Cameron G McCarthy  1   2 , Camilla F Wenceslau  1   2 , R Clinton Webb  3 , Bina Joe  1   2
Affiliations
Review

Novel Contributors and Mechanisms of Cellular Senescence in Hypertension-Associated Premature Vascular Aging

Cameron G McCarthy et al. Am J Hypertens. .

Abstract

Hypertension has been described as a condition of premature vascular aging, relative to actual chronological age. In fact, many factors that contribute to the deterioration of vascular function as we age are accelerated in hypertension. Nonetheless, the precise mechanisms that underlie the aged phenotype of arteries from hypertensive patients and animals remain elusive. Cellular senescence is an age-related physiologic process in which cells undergo irreversible growth arrest. Although controlled senescence negatively regulates cell proliferation and promotes tissue regeneration, uncontrolled senescence can contribute to disease pathogenesis by presenting the senescence-associated secretory phenotype, in which molecules such as proinflammatory cytokines, matrix metalloproteases, and reactive oxygen species are released into tissue microenvironments. This review will address and critically evaluate the current literature on the role of cellular senescence in hypertension, with particular emphasis on cells types that mediate and modulate vascular function and structure.

Keywords: blood pressure; cellular senescence; hypertension; vascular aging.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relative vascular age is accelerated in hypertension. For any given chronological age, a hypertensive patient or animal has an increased vascular age, compared with an age-matched normotensive control. The definition of vascular age encompasses a broad range of phenotypes that can refined into taxonomies such as hypercontractility, stiffening and remodeling, and inflammation and oxidative stress.
Figure 2.
Figure 2.
The senescence-associated secretory phenotype from endothelial cells and vascular smooth muscle cells, as well as T cells, fibroblasts, and perivascular adipose tissue (PVAT) synergize to cause vascular wall inflammation and dysfunction, driving the development and/or maintenance of hypertension.
Figure 3.
Figure 3.
Autophagy is able to prevent the aged phenotype in endothelial cells. Efficient degradation of dysfunctional organelles and misfolded protein aggregates prevents their accumulation and the induction of oxidative stress, which subsequently reduces nitric oxide bioavailability. Inefficient recycling of cellular waste occurs in both chronological aging and premature aging associated with cardiovascular diseases. Abbreviations: ROS, reactive oxygen species; SASP, senescence-associated secretory phenotype.
Figure 4.
Figure 4.
Our current understanding of senescence in hypertension-associated vascular aging, beyond phenotypic recognition, is far from complete. Most of the literature indicates a pressure-dependent association between increased cellular senescence and hypertension. However, there are no current studies demonstrating whether senescence can mediate increases in blood pressure, nor if removal of senescent cells (senolytic therapy) can lower blood pressure and improve vascular function in arteries from hypertensive animals.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thomas H. Senescence, ageing and death of the whole plant. New Phytol 2013; 197:696–711. - PubMed
    1. Faconti L, Bruno RM, Ghiadoni L, Taddei S, Virdis A. Ventricular and vascular stiffening in aging and hypertension. Curr Hypertens Rev 2015; 11:100–109. - PubMed
    1. Writing Group Members , Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB; American Heart Association Statistics Committee, Stroke Statistics Subcommittee . Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016;133:e38–360. - PubMed
    1. Abeywardena MY, Jablonskis LT, Head RJ. Age- and hypertension-induced changes in abnormal contractions in rat aorta. J Cardiovasc Pharmacol 2002; 40:930–937. - PubMed
    1. Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension 2017; 70:660–667. - PubMed

Publication types

  NODES
Association 3
twitter 2